$Approaches to the therapy of heart failure with reduced ejection fraction. Resolution of an online meeting of the Volga Federal District experts$

Approaches to the therapy of heart failure with reduced ejection fraction. Resolution of an online meeting of the Volga Federal District experts

At an online meeting of experts held on May 14, 2021 additional research results on a sodium-glucose co-transporter-2 (SGLT2) inhibitor empagliflozin in patients with heart failure with reduced ejection fraction were considered. According to the data from the EMPEROR-Reduced international study, car...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. S. Galyavich, I. V. Fomin, I. R. Gaisin, F. V. Valeeva, N. G. Vinogradova, A. S. Salasyuk, E. I. Tarlovskaya, N. R. Khasanov, A. M. Shutov, E. N. Volodina, L. V. Grekhova, P. S. Guseva, D. V. Duplyakov, O. V. Zanozina, Yu. V. Zolotova, S. V. Kanysheva, Z. F. Kim, S. K. Kononov, V. P. Kuzmin, S. S. Markiyanova, M. V. Menzorov, S. A. Pomosov, A. P. Rebrov, S. N. Tolstov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2022-02-01
Series:	Российский кардиологический журнал
Subjects:	empagliflozin heart failure cardiovascular mortality chronic kidney disease emperor-reduced study
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4791
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Approaches to the therapy of heart failure with reduced ejection fraction. Resolution of an online meeting of the Volga Federal District experts

Similar Items